Company Overview of C Sixty Inc.
C Sixty Inc. is a nanomedicine company that focuses on development of fullerenes based biopharmaceutical products. The company develops fullerene antioxidants that are used in the treatment of central nervous system (CNS) neurodegenerative diseases, strokes, cardiovascular diseases, and other acute and chronic diseases related to oxidative injury. C Sixty was founded in 1999 and is based in Houston, Texas. C Sixty Inc. operates as a subsidiary of Arrowhead Research Corp.
2250 Holcombe Boulevard
Houston, TX 77030
Founded in 1999
Key Executives for C Sixty Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact C Sixty Inc., please visit www.csixty.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.